Product testing in Australia reveals inconsistencies over cannabinoid potency
Prohibition Partners LIVE returns this November with global cannabis conference
European Cannabis: Waking The Sleeping Giant
Prohibition Partners Interviews Pharmin’s CEO Ana Kobalia
Germany: Insured medicinal cannabis sales worth €75 million in the first half of 2020
Recreational cannabis projects beginning to emerge in Europe
Prohibition Partners interviews cannabinoid expert D’Arcy Bond from Newell Sciences
US Congressional Committee Approves the Medical Cannabis Research Act
Key insights from THE IMPACT SERIES: Disrupting Food